FDA: Don’t rush into changing Covid-19 vaccine composition
An Tuesday, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 19-2 to approve the use later this year of Covid-19 vaccines based on an Omicron variant sequence. One of us (PAO) was among those voting “no.” It is possible these vaccines will be two-component designs that also include the current version. Will … Read more